Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK2 | O60674 | 1/20 | 1.00 |
| ▸ | THRB | P10828 | 1/20 | 1.00 |
| ▸ | DHODH | Q02127 | 13/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | TYMP | P19971 | 1/20 | 0.34 |
| ▸ | EIF4A3 | P38919 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9715507 | 1.00 | JAK2 (1.00) | JAK2THRBDHODHLMNAALDH1A1 | |
| Water SCHEMBL147605 | 0.98 | JAK2 (0.96) | JAK2THRBDHODHLMNAALDH1A1 | |
| SCHEMBL10627886 | 0.98 | JAK2 (0.96) | JAK2THRBDHODHLMNAALDH1A1 | |
| SCHEMBL10629768 | 0.98 | JAK2 (0.96) | JAK2THRBDHODHLMNAALDH1A1 | |
| SCHEMBL17930149 | 0.80 | JAK2 (0.67) | JAK2THRBDHODHLMNAALDH1A1 | |
| Lithium Ion SCHEMBL10629765 | 0.78 | JAK2 (0.64) | JAK2THRBLMNAALDH1A1TYMP | |
| SCHEMBL10627877 | 0.78 | JAK2 (0.64) | JAK2THRBLMNAALDH1A1TYMP | |
| SCHEMBL22783664 | 0.77 | JAK2 (0.61) | JAK2THRBDHODHLMNAALDH1A1 | |
| SCHEMBL9715512 | 0.76 | JAK2 (0.58) | JAK2THRB | |
| SCHEMBL21886927 | 0.75 | THRB (0.60) | JAK2THRBDHODHALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7345 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122038155-A | Recombinant yarrowia lipolytica strain Ylscu-03 for producing scutellarin, and construction method and application thereof | 华东理工大学 | 2026-05-15 | — | — | CN | claimed |
| US-20260062724-A1 | MUTANT WICKERHAMMYCES CIFERRll STRAIN HAVING IMPROVED PRODUCTIVITY FOR TAPS, AND METHOD FOR PRODUCING TAPS USING SAME | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (KR) | 2026-03-05 | — | — | US | claimed |
| EP-4127157-B1 | MODIFIED DIPEPTIDE CLEAVASES, USES THEREOF AND RELATED KITS | ENCODIA INC (US) | 2026-02-11 | — | — | EP | claimed |
| US-12540315-B2 | Compositions and methods for using genetically modified enzymes | RENEW BIOPHARMA, INC. (US) | 2026-02-03 | — | — | US | claimed |
| EP-4560315-A2 | HYBRIDIZING ALL-LNA OLIGONUCLEOTIDES | F. Hoffmann-La Roche AG (CH) | 2025-05-28 | — | — | EP | claimed |
| US-20250152640-A1 | MICROORGANISMS WITH REDUCED COMPETENCE | EVONIK OPERATIONS GMBH (DE) | 2025-05-15 | — | — | US | claimed |
| CN-119932082-A | Recombinant trichoderma reesei strain and construction method and application thereof | 浙江工业大学 | 2025-05-06 | — | — | CN | claimed |
| CN-119899755-A | Yarrowia lipolytica strain for high squalene yield, construction method thereof and application method thereof in squalane synthesis | 华东理工大学 | 2025-04-29 | — | — | CN | claimed |
| WO-2025079010-A1 | A METHOD FOR INCREASING THE GROWTH RATE OF HALOPHILIC ARCHAEA BY MITIGATING THE EFFECTS OF PROVIRUSES WITHIN THEIR GENOMES | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2025-04-17 | — | — | WO | claimed |
| CN-119709809-A | Genetic modification method of bordetella pertussis and application thereof | 北京科兴中维生物技术有限公司 | 2025-03-28 | — | — | CN | claimed |
| WO-1995014769-A1 | TRANSGENIC MOUSE PREPARED USING YEAST ARTIFICIAL CHROMOSOMES (YACs) AND HOMOLOGOUS RECOMBINATION | UNIVERSITY OF SOUTH FLORIDA (US) | 1995-06-01 | — | — | WO | claimed |
| WO-1994026761-A1 | TREATMENT OF CHEMOTHERAPEUTIC AGENT AND ANTIVIRAL AGENT TOXICITY WITH ACYLATED PYRIMIDINE NUCLEOSIDES | PRO-NEURON, INC. (US) | 1994-11-24 | — | — | WO | claimed |
| EP-0594667-A1 | TREATMENT OF CHEMOTHERAPEUTIC AGENT AND ANTIVIRAL AGENT TOXICITY WITH ACYLATED PYRIMIDINE NUCLEOSIDES | PRO-NEURON, INC. (US) | 1994-05-04 | — | — | EP | claimed |
| WO-1993001202-A1 | TREATMENT OF CHEMOTHERAPEUTIC AGENT AND ANTIVIRAL AGENT TOXICITY WITH ACYLATED PYRIMIDINE NUCLEOSIDES | PRO-NEURON, INC. (US) | 1993-01-21 | — | — | WO | claimed |
| EP-0445239-A4 | ANTI-MALARIAL COMPOSITION AND METHOD OF USE | — | 1992-03-25 | — | — | EP | claimed |
| EP-0445239-A1 | ANTI-MALARIAL COMPOSITION AND METHOD OF USE | THE CATHOLIC UNIVERSITY OF AMERICA (US) | 1991-09-11 | — | — | EP | claimed |
| WO-1991000081-A2 | ANTI-MALARIAL COMPOSITION AND METHOD OF USE | THE CATHOLIC UNIVERSITY OF AMERICA (US) | 1991-01-10 | — | — | WO | claimed |
| US-4839285-A | FROM CULTURES OF BACILLUS SUBTILIS WHICH ARE DEFICIENT IN CYTIDINE DEAMINASE ACTIVITY AND RESISTANT TO URACIL DERIVATAIVES; EFFICIENCY | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1989-06-13 | — | — | US | claimed |
| US-4755388-A | Antiproliferative agent in liposome of cholesterol and phosphatidylglycerol | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1988-07-05 | — | — | US | claimed |
| US-4186266-A | Process for producing 5-fluorouracil | ASAHI GLASS COMPANY LIMITED (JP) | 1980-01-29 | — | — | US | claimed |